Keeping left ventricular assist device acceleration on track

Circulation

Volumn 123, Issue 14, 2011, Pages 1559-1568

  Stewart, Garrick C ^a   Stevenson, Lynne W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; INOTROPIC AGENT;

ANTICOAGULATION; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASSISTED CIRCULATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR EQUIPMENT; GASTROINTESTINAL HEMORRHAGE; GERIATRIC DISORDER; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LEFT VENTRICULAR ASSIST DEVICE THERAPY; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

AGE FACTORS; AGED; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79954587401     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.982512     Document Type: Article

References (49)

1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001; 345:1435-1443.
2. National Coverage Determination (NCD) Manual 100-03 20
3. Artificial hearts and related devices. Baltimore, MD: Centers for Medicare and Medicaid Services; October 1, 2003.
4. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN III. Chronic mechanical circulatory support for inotropedependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741-747. (Pubitemid 47239315)
5. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM III, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361: 2241-2251.
6. Fang JC. Rise of the machines-left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med. 2009;361: 2282-2285.
7. Kirklin JK, Naftel DC. Mechanical circulatory support: registering a therapy in evolution. Circ Heart Fail. 2008;1:200-205.
8. intermacs. www.intermacs.org. Accessed October 2010.
9. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535-541.
10. Pagani FD, Naftel DC, Aaronson KD, Parides MK, Farrar DJ, Pamboukian SV, Kirklin JK. Changing characteristics of patients receiving mechanically assist circulatory support in INTERMACS. J Heart Lung Transplant. 2010;29:S27.
11. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1-10.
12. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, Cleeton T, Koenig SC, Edwards L, Kirklin JK. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009;28:44-50.
13. Stewart GC, Brooks K, Pratibhu PP, Tsang SW, Semigran MJ, Smith CM, Saniuk C, Camuso JM, Fang JC, Mudge GH, Couper GS, Baughman KL, Stevenson LW. Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices. J Heart Lung Transplant. 2009;28:863-869.
14. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55:1826 -1834.
15. Stevenson LW, Hamilton MA, Tillisch IH, Moriguchi JD, Kobashigawa JA, Creaser JA, Drinkwater D, Laks H. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol. 1991;18:919-925.
16. Stevenson LW. When is heart failure a surgical disease? In: Rose EA, Stevenson LW, eds. Management of end-stage heart disease. Philadelphia, PA: Lippincott-Raven Publishers; 1998:chap 10.
17. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005. J Am Coll Cardiol. 2007;50:1282-1290. (Pubitemid 47405140)
18. Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation. 2007;115: 204-212. (Pubitemid 46105719)
19. Bristow MR. beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000;101:558-569. (Pubitemid 30080872)
20. Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Staiger C, Holcslaw TL, Amann-Zalan I, DeMets DL. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194-2199. (Pubitemid 35222212)
21. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717. (Pubitemid 29407370)
22. Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993;270: 1702-1707. (Pubitemid 23295315)
23. Stevenson LW, Sietsema K, Tillisch JH, Lem V, Walden J, Kobashigawa JA, Moriguchi J. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation. 1990;81:78-85. (Pubitemid 20031770)
24. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. J Card Fail. 2010;16:855-858.
25. Rogers JG, Pagani FD, Kirklin JK, Naftel DC, Morris RJ, Dembitsky WP, Blood MS, Young JB. Survival after implant of a left ventricular assist device: is it the device or is it the patient? J Heart Lung Transplant. 2010;29:S40.
26. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006;25:1024-1042. (Pubitemid 44311532)
27. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260-266. (Pubitemid 47079017)
28. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Zuckermann AO, Wieselthaler GM. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation. J Heart Lung Transplant. 2009;28:367-372.
29. Stepanenko A, Potapov EV, Jurmann B, Lehmkuhl HB, Dandel M, Siniawski H, Drews T, Hennig E, Kaufmann F, Jurmann MJ, Weng Y, Pasic M, Hetzer R, Krabatsch T. Outcomes of elective versus emergent permanent mechanical circulatory support in the elderly: a single-center experience. J Heart Lung Transplant. 2010;29:61-65.
30. Selection of cardiac transplantation candidates in 2010. Circulation. 2010;122:173-183
31. Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, Hernandez AF, Rogers JG, Milano CA. Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Thorac Surg. 2010;89:1205-1209, discussion 1210.
32. Wilson SR, Mudge GH Jr, Stewart GC, Givertz MM. Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation. 2009;119:2225-2232.
33. Torre-Amione G, Southard RE, Loebe MM, Youker KA, Bruckner B, Estep JD, Tierney M, Noon GP. Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. J Heart Lung Transplant. 2010;29:195-200.
34. Nair PK, Kormos RL, Teuteberg JJ, Mathier MA, Bermudez CA, Toyoda Y, Dew MA, Simon MA. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant. 2010;29:201-208.
35. John R, Liao K, Kamdar F, Eckman P, Boyle A, Colvin-Adams M. Effects on pre-and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2010;140:447-452.
36. Palardy M, Nohria A, Rivero J, Lakdawala N, Campbell P, Kato M, Griffin LM, Smith CM, Couper GS, Stevenson LW, Givertz MM. Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail. 2010;16:218-224.
37. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505. (Pubitemid 47450258)
38. Fitzpatrick JR III, Frederick JR, Hsu VM, Kozin ED, O'Hara ML, Howell E, Dougherty D, McCormick RC, Laporte CA, Cohen JE, Southerland KW, Howard JL, Jessup ML, Morris RJ, Acker MA, Woo YJ. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27: 1286-1292.
39. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163-2172. (Pubitemid 351713685)
40. Taleb NN. The Black Swan: The Impact of the Highly Improbable. 2nd ed. New York, NY: Random House; 2010.
41. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321.
42. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009;53:2162-2167.
43. Stern DR, Kazam J, Edwards P, Maybaum S, Bello RA, D'Alessandro DA, Goldstein DJ. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 2010;25: 352-356.
44. Matthews JC, Aaronson KD, Jain R, Pagani FD, Kolias TJ. Aortic insufficiency-trends over time in LVAD supported patients. J Heart Lung Transplant. 2009;28:S306.
45. Park SJ, Liao KK, Segurola R, Madhu KP, Miller LW. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch). J Thorac Cardiovasc Surg. 2004;127:264-266. (Pubitemid 38160493)
46. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29 (4 suppl):S1-S39.
47. Myers TJ, Bolmers M, Gregoric ID, Kar B, Frazier OH. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009;28:423-427.
48. Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K, Pasque MK, Moon MR, Damiano RJ Jr, Moazami N. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007;84:515-520. (Pubitemid 47069197)
49. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Miller LW, Deng M, Naka Y, Mancini D. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005. Circ Heart Fail. 2009;2:3-10.